Search results
Results from the WOW.Com Content Network
Cryotherapy is a specific type of low-temperature treatment used to reduce inflammation and its associated pain. [4] Cryotherapy was developed in the 1970s by Japanese rheumatologist Toshima Yamaguchi [5] [6] and introduced to Europe, US and Australia in the 1980s [7] [8] and 1990s. [9]
Warts, moles, skin tags, solar keratoses, molluscum, [4] Morton's neuroma [5] and small skin cancers are candidates for cryosurgical treatment. Several internal disorders are also treated with cryosurgery, including liver cancer, prostate cancer, lung cancer, oral cancers, cervical disorders and, more commonly in the past, hemorrhoids.
The SPC is not intended to give general advice about treatment of a condition but does state how the product is to be used for a specific treatment. It forms the basis of information for health professionals to know how to use the specific product safely and effectively. The package leaflet supplied with the product is aimed at end-users. [3]
The majority of drugs used in cancer chemotherapy are cytostatic, many via cytotoxicity. A fundamental philosophy of medical oncology , including combination chemotherapy, is that different drugs work through different mechanisms, and that the results of using multiple drugs will be synergistic to some extent.
Cryoablation is used in two types of intervention for the treatment of arrhythmias: (1) catheter-based procedures and (2) surgical operations. A catheter is a very thin tube that is inserted into a vein in the patient’s leg and threaded to the heart where it delivers energy to treat the patient’s arrhythmia.
Metronidazole, sold under the brand name Flagyl among others, is an antibiotic and antiprotozoal medication. [10] It is used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis. [10]
Despite its advantages, IRE remains an experimental therapy, and larger, long-term studies are necessary to fully understand its efficacy and safety profile. As with any emerging medical treatment, patient selection is critical, and IRE should be considered within the broader context of an individual patient's treatment goals and overall health.
From 2012 to 2016, six ovarian cancer patients who could not be treated with conventional therapy were treated with metronomic cyclophosphamide. [23] Although the clinical outcomes do not only depend on metronomic therapy but also previous treatments they had received, the treatment provided the progress of ovarian cancers and one case was ...